Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition
Primary Purpose
Heart Failure With Preserved Ejection Fraction (HFpEF)
Status
Recruiting
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Adenosine stress echocardiography with the evaluation of coronary artery blood flow
Sponsored by
About this trial
This is an interventional diagnostic trial for Heart Failure With Preserved Ejection Fraction (HFpEF) focused on measuring body composition, CPET, CFR, coronary microvascular dysfunction (CMD), frailty, HFpEF
Eligibility Criteria
Inclusion Criteria:
- Age 20 to 80
- Typical/atypical chest pain or ischemic symptoms including dyspnea
- No significant coronary artery stenosis (>50% stenosis) in coronary angiography or computed tomography
- Left ventricular ejection fraction ≥50%
Exclusion Criteria:
- More than moderate valvular heart disease
- Congenital heart disease
- Chronic renal failure (estimated glomerular filtration rate <30 ml/min/1.73m2) or end-stage renal failure undergoing hemodialysis or peritoneal dialysis
- Asthma, chronic obstructive pulmonary disease and primary pulmonary hypertension
- Receiving anticancer drugs
- Vasculitis associated with autoimmune diseases
- Patients with difficulty in performing exercise load evaluation (treadmill, bicycle ergometer)
- Atrial fibrillation
- Atrioventricular block with more than second degrees, symptomatic bradycardia, cryo-node failure syndrome, Wolff-Parkinson-White (WPW) patients
Sites / Locations
- Korea University Anam HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Heart failure with preserved ejection fraction
Arm Description
Adenosine stress echocardiography, body composition, and cardiopulmonary exercise test will be done in all of the enrolled patients. Left ventricular end-diastolic pressure will be assessed during coronary angiography.
Outcomes
Primary Outcome Measures
Correlation of coronary blood flow with cardiopulmonary exercise capacity
Coronary blood flow is assessed by coronary flow reserve (CFR), which is defined as peak to baseline mean diastolic velocity of coronary flow.
In regard to cardiopulmonary exercise capacity, maximal oxygen consumption (VO2max) will be assessed.
Correlation of body composition with cardiopulmonary exercise capacity
In body composition analysis, skeletal muscle mass and body fat mass will be assessed.
In regard to cardiopulmonary exercise capacity, maximal oxygen consumption (VO2max) will be assessed.
Secondary Outcome Measures
Full Information
NCT ID
NCT04822649
First Posted
March 18, 2021
Last Updated
September 25, 2023
Sponsor
Korea University Anam Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04822649
Brief Title
Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition
Official Title
Differences in Cardiopulmonary Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition in Patients With Suspected Heart Failure With Preserved Ejection Fraction
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 15, 2021 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Korea University Anam Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The correlation of coronary microvascular function and body composition with cardiopulmonary exercise capacity will be assessed in patients with heart failure with preserved ejection fraction.
Detailed Description
We will select the patients with chest pain or ischemic symptoms with non-obstructive coronary artery disease (<50% stenosis) in coronary angiography and preserved ejection fraction (≥50%) in echocardiography. All patients will undergo body composition analysis and adenosine stress echocardiography with the evaluation of coronary artery blood flow by Doppler echocardiography and maximal oxygen consumption (VO2 max) by cardiopulmonary exercise test (CPET). Left ventricular end-diastolic pressure will be assessed during coronary angiography. Coronary flow reserve (CFR) is defined as the ratio of peak to baseline mean diastolic velocity of coronary blood flow. The correlation of CFR and body composition with cardiopulmonary exercise capacity will be assessed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure With Preserved Ejection Fraction (HFpEF)
Keywords
body composition, CPET, CFR, coronary microvascular dysfunction (CMD), frailty, HFpEF
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Patients with chest pain or ischemic symptoms with non-obstructive coronary artery disease (<50% stenosis) in coronary angiography and preserved ejection fraction (>50%) in echocardiography.
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Heart failure with preserved ejection fraction
Arm Type
Other
Arm Description
Adenosine stress echocardiography, body composition, and cardiopulmonary exercise test will be done in all of the enrolled patients. Left ventricular end-diastolic pressure will be assessed during coronary angiography.
Intervention Type
Diagnostic Test
Intervention Name(s)
Adenosine stress echocardiography with the evaluation of coronary artery blood flow
Other Intervention Name(s)
Body composition analysis, Cardiopulmonary exercise test
Intervention Description
The color Doppler flow of distal left anterior descending artery will be examined from the modified apical four-chamber view in the anterior interventricular groove.
In regard to body composition analysis, Using InBody S10, impedance is measured in 6 frequency bands (1 kilohertz (kHz), 5 kHz, 50 kHz, 250 kHz, 500 kHz, 1000 kHz) for each of 5 parts (right plate, left arm, torso, right leg, left leg). Reactance is measured in 3 frequency bands (5 kHz, 50 kHz, 250 kHz for each of 5 parts (right arm, left arm, torso, right leg, left leg).
By treadmill exercise test with modified Bruce protocol or bicycle ergometer for patients with orthopedic problems, maximal oxygen consumption (VO2 max) will be measured using the exhalation gas analysis.
Primary Outcome Measure Information:
Title
Correlation of coronary blood flow with cardiopulmonary exercise capacity
Description
Coronary blood flow is assessed by coronary flow reserve (CFR), which is defined as peak to baseline mean diastolic velocity of coronary flow.
In regard to cardiopulmonary exercise capacity, maximal oxygen consumption (VO2max) will be assessed.
Time Frame
up to day 14
Title
Correlation of body composition with cardiopulmonary exercise capacity
Description
In body composition analysis, skeletal muscle mass and body fat mass will be assessed.
In regard to cardiopulmonary exercise capacity, maximal oxygen consumption (VO2max) will be assessed.
Time Frame
up to day 14
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 20 to 80
Typical/atypical chest pain or ischemic symptoms including dyspnea
No significant coronary artery stenosis (>50% stenosis) in coronary angiography or computed tomography
Left ventricular ejection fraction ≥50%
Exclusion Criteria:
More than moderate valvular heart disease
Congenital heart disease
Chronic renal failure (estimated glomerular filtration rate <30 ml/min/1.73m2) or end-stage renal failure undergoing hemodialysis or peritoneal dialysis
Asthma, chronic obstructive pulmonary disease and primary pulmonary hypertension
Receiving anticancer drugs
Vasculitis associated with autoimmune diseases
Patients with difficulty in performing exercise load evaluation (treadmill, bicycle ergometer)
Atrial fibrillation
Atrioventricular block with more than second degrees, symptomatic bradycardia, cryo-node failure syndrome, Wolff-Parkinson-White (WPW) patients
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
So Ree Kim, MD
Phone
821094534810
Email
soree8826kim@gmail.com
Facility Information:
Facility Name
Korea University Anam Hospital
City
Seoul
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
So Ree Kim, MD
Email
soree8826kim@gmail.com
First Name & Middle Initial & Last Name & Degree
Seong-Mi Park
First Name & Middle Initial & Last Name & Degree
Mi-Na Kim
First Name & Middle Initial & Last Name & Degree
So Ree Kim
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
36262558
Citation
Kim SR, Cho DH, Kim MN, Park SM. Rationale and Study Design of Differences in Cardiopulmonary Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition in Patients with Suspected Heart Failure with Preserved Ejection Fraction. Int J Heart Fail. 2021 Sep 14;3(4):237-243. doi: 10.36628/ijhf.2021.0029. eCollection 2021 Oct.
Results Reference
derived
Learn more about this trial
Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition
We'll reach out to this number within 24 hrs